tradingkey.logo
tradingkey.logo
Suchen

AtriCure Inc

ATRC
Zur Watchlist hinzufügen
31.345USD
+1.615+5.43%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
1.56BMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über AtriCure Inc Unternehmen

AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.

AtriCure Inc Informationen

BörsenkürzelATRC
Name des UnternehmensAtriCure Inc
IPO-datumAug 05, 2005
CEOCarrel (Michael H)
Anzahl der mitarbeiter1300
WertpapierartOrdinary Share
GeschäftsjahresendeAug 05
Addresse7555 Innovation Way
StadtMASON
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl45040
Telefon15137554100
Websitehttps://www.atricure.com
BörsenkürzelATRC
IPO-datumAug 05, 2005
CEOCarrel (Michael H)

Führungskräfte von AtriCure Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Michael H. (Mike) Carrel, CPA
Mr. Michael H. (Mike) Carrel, CPA
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
796.06K
+12.20%
Mr. Salvatore Privitera, J.D.
Mr. Salvatore Privitera, J.D.
Chief Technical Officer
Chief Technical Officer
158.05K
+20.54%
Mr. Robert S. (Bob) White
Mr. Robert S. (Bob) White
Independent Chairman of the Board
Independent Chairman of the Board
128.32K
+4.79%
Mr. Justin J. Noznesky
Mr. Justin J. Noznesky
Chief Marketing and Strategy Officer
Chief Marketing and Strategy Officer
106.40K
+25.94%
Mr. Karl S. Dahlquist, J.D.
Mr. Karl S. Dahlquist, J.D.
Chief Legal Officer
Chief Legal Officer
96.05K
+28.63%
Dr. Vinayak Doraiswamy, Ph.D.
Dr. Vinayak Doraiswamy, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
91.88K
-5.44%
Mr. Sven A. Wehrwein, CPA
Mr. Sven A. Wehrwein, CPA
Independent Director
Independent Director
40.52K
+15.16%
Ms. Regina E. (Reggie) Groves
Ms. Regina E. (Reggie) Groves
Independent Director
Independent Director
39.86K
+15.41%
Ms. Deborah H. (Deb) Telman
Ms. Deborah H. (Deb) Telman
Independent Director
Independent Director
28.33K
+21.69%
Mr. Shlomo Nachman
Mr. Shlomo Nachman
Independent Director
Independent Director
24.66K
+24.92%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Michael H. (Mike) Carrel, CPA
Mr. Michael H. (Mike) Carrel, CPA
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
796.06K
+12.20%
Mr. Salvatore Privitera, J.D.
Mr. Salvatore Privitera, J.D.
Chief Technical Officer
Chief Technical Officer
158.05K
+20.54%
Mr. Robert S. (Bob) White
Mr. Robert S. (Bob) White
Independent Chairman of the Board
Independent Chairman of the Board
128.32K
+4.79%
Mr. Justin J. Noznesky
Mr. Justin J. Noznesky
Chief Marketing and Strategy Officer
Chief Marketing and Strategy Officer
106.40K
+25.94%
Mr. Karl S. Dahlquist, J.D.
Mr. Karl S. Dahlquist, J.D.
Chief Legal Officer
Chief Legal Officer
96.05K
+28.63%
Dr. Vinayak Doraiswamy, Ph.D.
Dr. Vinayak Doraiswamy, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
91.88K
-5.44%

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von AtriCure Inc?

Die fünf größten Anteilseigner von AtriCure Inc sind: Mr. Michael H. (Mike) Carrel, CPA

Wie viele Institutionen halten Anteile an AtriCure Inc (ATRC)?

Mit Stand vom 2026Q1 halten 505 Institutionen Anteile an AtriCure Inc, mit einem Gesamtmarktwert von etwa 48.18M, was 95.14% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -7010307.00 gestiegen.

Was ist die größte Einnahmequelle von AtriCure Inc?

Am 2026Q1 erzielte das Geschäft mit Appendage Management-United states für AtriCure Inc den höchsten Umsatz in Höhe von 178.13M, was 33.32% des Gesamtumsatzes entspricht.